Molecular Templates, Inc. Reports Fourth Quarter 2019 Financial Results

NEXT STORY
Translate Bio Announces Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Progress
PREV STORY
Homology Medicines Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Accomplishments
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Sanofi: Dupixent® (dupilumab) showed positive Phase 3 results in adolescents with inadequately controlled moderate-to-severe atopic dermatitis

  Press ReleaseSource: Sanofi (EURONEXT: SAN) (NYSE: SNY) Dupixent® (dupilumab) showed positive Phase 3 ...

author_avatar
NASDAQ Market News

Progenics Pharmaceuticals Announces Positive Topline Results from Registrational Phase 2b Trial of AZEDRA®

- Novel, targeted radiotherapeutic for malignant and/or recurrent pheochromocytoma and paraganglioma –- Study achieves ...

author_avatar
NASDAQ Market News

Achaogen to Host R&D Day Focused on Advances and Opportunities in the Treatment of Resistant Gram-Negative Infections

SOUTH SAN FRANCISCO, Calif., Feb. 15, 2017 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ:AKAO), a ...

author_avatar
NASDAQ Market News